US2008248019A1PendingUtilityA1
Recombinant beta-galactosidase derived from Streptococcus pneumaniae
Assignee: KOREA RES INST OF BIOSCIENCEPriority: Jun 23, 2006Filed: Jun 25, 2007Published: Oct 9, 2008
Est. expiryJun 23, 2026(expired)· nominal 20-yr term from priority
C12Y 302/01023A61P 35/00A61K 38/00C12N 9/2471C12N 15/10C12N 9/00C12N 9/2468
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a novel beta-galactosidase derived from Streptococcus pneumoniae , a BgaC protein exhibiting the enzyme activity, and a method for using the same. The protein can be used in the modification and analysis of sugar chain and used as an anti-cancer agent.
Claims
exact text as granted — not AI-modified1 . A protein exhibiting beta-galactosidase enzyme activity, which has an amino acid sequence represented by SEQ ID NO: 2, or an amino acid sequence having at least 90% homology therewith.
2 . The protein according to claim 1 , wherein the beta-galactosidase selectively hydrolyzes the galactose in the structure of galactose-β1, 3-N-acetylglucosamine.
3 . The protein according to claim 1 , which has the following characteristics of (a) to (d):
(a) maximum activity in the temperature range of 20 to 40° C.; (b) maximum activity at a pH range of 5.0 to 8.0; (c) a molecular weight of 50 to 100 kDa; and (d) more reactivity and higher substrate specificity to PNPG than to ONPG.
4 . An isolated nucleic acid molecule encoding the protein of claim 1 .
5 . An expression vector comprising the nucleic acid molecule of claim 4 .
6 . The expression vector according to claim 5 , shown in FIG. 1B .
7 . A transformant transformed by the expression vector of claim 6 .
8 . The transformant according to claim 7 , which has a deposit number of KCTC10956BP.
9 . A method for linkage-specifically cleaving the galactose and modified sugar chain in the structure of galactose-beta 1,3-N-acetylglucosamine using the protein according to any one of claims 1 to 3 .
10 . A method for linkage-specifically analyzing the structure of a sugar chain by treating with the protein according to any one of claims 1 to 3 .
11 . A composition for inhibiting tumor, comprising the protein according to any one of claims 1 to 3 as an active ingredient.Join the waitlist — get patent alerts
Track US2008248019A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.